236 related articles for article (PubMed ID: 34012297)
1. USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR/4EBP1 Activation.
Li Y; Zhou J
Cancer Manag Res; 2021; 13():3913-3924. PubMed ID: 34012297
[TBL] [Abstract][Full Text] [Related]
2. GNA14 stimulation of KLF7 promotes malignant growth of endometrial cancer through upregulation of HAS2.
Wang J; Teng F; Chai H; Zhang C; Liang X; Yang Y
BMC Cancer; 2021 Apr; 21(1):456. PubMed ID: 33892667
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of PSAT1 inhibits cell proliferation and migration in uterine corpus endometrial carcinoma.
Wang M; Yue S; Yang Z
Sci Rep; 2023 Mar; 13(1):4081. PubMed ID: 36906716
[TBL] [Abstract][Full Text] [Related]
4. Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation.
Yuan Y; Chen Z; Cai X; He S; Li D; Zhao W
Front Oncol; 2021; 11():766947. PubMed ID: 34868993
[TBL] [Abstract][Full Text] [Related]
5. USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1.
Li G; Yang T; Chen Y; Bao J; Wu D; Hu X; Feng C; Xu L; Li M; Li G; Jin M; Xu Y; Zhang R; Qian G; Pan J
Front Pharmacol; 2021; 12():720307. PubMed ID: 34483932
[TBL] [Abstract][Full Text] [Related]
6. Usp5 functions as an oncogene for stimulating tumorigenesis in hepatocellular carcinoma.
Liu Y; Wang WM; Lu YF; Feng L; Li L; Pan MZ; Sun Y; Suen CW; Guo W; Pang JX; Zhang JF; Fu WM
Oncotarget; 2017 Aug; 8(31):50655-50664. PubMed ID: 28881591
[TBL] [Abstract][Full Text] [Related]
7. The Circadian Gene NPAS2 Act as a Putative Tumor Stimulative Factor for Uterine Corpus Endometrial Carcinoma.
Zheng X; Lv X; Zhu L; Xu K; Shi C; Cui L; Ding H
Cancer Manag Res; 2021; 13():9329-9343. PubMed ID: 34992456
[TBL] [Abstract][Full Text] [Related]
8. Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.
Zhang Z; Cui Z; Xie Z; Li C; Xu C; Guo X; Yu J; Chen T; Facchinetti F; Bohnenberger H; Leong TL; Xie Y; Mao X; Zhao J
Transl Lung Cancer Res; 2021 Oct; 10(10):3995-4011. PubMed ID: 34858787
[TBL] [Abstract][Full Text] [Related]
9. USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway.
Cao L; Liu H; Huang C; Guo C; Zhao L; Gao C; Xu Y; Wang G; Liang N; Li S
Biol Direct; 2023 Apr; 18(1):16. PubMed ID: 37060095
[TBL] [Abstract][Full Text] [Related]
10. LHX1 as a potential biomarker regulates EMT induction and cellular behaviors in uterine corpus endometrial carcinoma.
Tian Y; Wen F; Wang S; Lv N
Clinics (Sao Paulo); 2022; 77():100103. PubMed ID: 36116266
[TBL] [Abstract][Full Text] [Related]
11. Discovery of therapeutic targets of quercetin for endometrial carcinoma patients infected with COVID-19 through network pharmacology.
Li K; Liu H; Lin Y; Gu L; Xiang X; Zhu X
Front Oncol; 2023; 13():1151434. PubMed ID: 36969077
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin specific peptidase 5 enhances STAT3 signaling and promotes migration and invasion in Pancreatic Cancer.
Lian J; Liu C; Guan X; Wang B; Yao Y; Su D; Ma Y; Fang L; Zhang Y
J Cancer; 2020; 11(23):6802-6811. PubMed ID: 33123271
[No Abstract] [Full Text] [Related]
13. Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer.
Li J; Xu W; Zhu Y
Oncol Lett; 2020 Nov; 20(5):255. PubMed ID: 32994818
[TBL] [Abstract][Full Text] [Related]
14. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma.
He K; Li J; Huang X; Zhao W; Wang K; Wang T; Chen J; Wang Z; Yi J; Zhao S; Zhao L
Front Oncol; 2023; 13():1090779. PubMed ID: 36776306
[TBL] [Abstract][Full Text] [Related]
15. USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.
Zhang HH; Zhang AQ; Peng P; Huang L; Liu CY; Nie XR; Hou DF; Zhang X; Li SZ
Cancer Cell Int; 2024 Jan; 24(1):32. PubMed ID: 38229092
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma.
Jiang N; Li D; Han Y; Luo ZG; Liu LB
Aging (Albany NY); 2024 Jun; 16():. PubMed ID: 38848146
[TBL] [Abstract][Full Text] [Related]
17. PHF6 promotes the progression of endometrial carcinoma by increasing cancer cells growth and decreasing T-cell infiltration.
Wang X; Fang A; Peng Y; Yu J; Yu C; Xie J; Zheng Y; Song L; Li P; Li J; Kang X; Lin Y; Li W
J Cell Mol Med; 2023 Mar; 27(5):609-621. PubMed ID: 36756714
[TBL] [Abstract][Full Text] [Related]
18. A pan-cancer analysis of the role of USP5 in human cancers.
Yan B; Guo J; Deng S; Chen D; Huang M
Sci Rep; 2023 Jun; 13(1):8972. PubMed ID: 37268697
[TBL] [Abstract][Full Text] [Related]
19. CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma.
Xue S; Su XM; Ke LN; Huang YG
Front Oncol; 2023; 13():1077780. PubMed ID: 36845675
[TBL] [Abstract][Full Text] [Related]
20. USP5 Promotes Metastasis in Non-Small Cell Lung Cancer by Inducing Epithelial-Mesenchymal Transition
Xue S; Wu W; Wang Z; Lu G; Sun J; Jin X; Xie L; Wang X; Tan C; Wang Z; Wang W; Ding X
Front Pharmacol; 2020; 11():668. PubMed ID: 32477134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
